Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Norske pasienter med tykktarmskreft kommer for sent i gang med tilleggsbehandling
Engelsk titel: Norwegian patients with colon cancer start their adjuvant therapy too late Läs online Författare: Olsen, Frank ; Uleberg, Bård ; Jacobsen, Bjarne Koster ; Balteskard, Lise Språk: Nor Antal referenser: 6 Dokumenttyp: Artikel UI-nummer: 16037171

Tidskrift

Tidsskrift for Den Norske Laegeforening 2016;136(1)27-31 ISSN 0029-2001 E-ISSN 0807-7096 KIBs bestånd av denna tidskrift

Sammanfattning

BACKGROUND For patients with colon cancer who are to receive adjuvant chemotherapy according to national guidelines, such therapy must be initiated no more than 4-6 weeks after the surgical intervention. We wished to investigate whether these guidelines are being complied with. We also wished to see whether the type of surgery (open or laparoscopic) had any effect on the time elapsing before initiation of adjuvant therapy. MATERIAL AND METHOD The material includes 1 132 patients who had undergone surgery for colon cancer in the period 2008-2013 and who received adjuvant chemotherapy. Surgical treatment and adjuvant chemotherapy are defined through diagnosis and procedural codes in the Norwegian Patient Register for the period 2008-2013. RESULTS On average, 44.7 days passed after the surgical intervention before the patients commenced their adjuvant chemotherapy. For 49 % of the patients, the adjuvant therapy was not initiated within the six-week deadline. Patients who had undergone laparoscopic surgery were hospitalised for shorter periods (6.5 days versus 10.7 days) and had fewer complications (7.6 % versus 16.4 %) when compared to patients who had undergone open surgery, yet still failed to start their adjuvant therapy correspondingly earlier. INTERPRETATION Measures should be taken to improve quality, thus ensuring that the guidelines are complied with and that patients start their required adjuvant therapy earlier. For those who have undergone laparoscopic surgery, it ought to be simple to reap the gains from shorter hospitalisation periods and fewer complications in the form of a more rapid initiation of adjuvant therapy.